Asia Bio-Chem Group Corp. Announces Resignation of Chief Financial Officer and Appointment of Interim Chief Financial Officer

TORONTO, Aug. 11, 2015 /CNW/ - Asia Bio-Chem Group Corp. (CSE: ABC) ("Asia Bio-Chem" or the "Company") announces today that Elaine Zhao has resigned as Chief Financial Officer ("CFO") and director of the Company effective July 31, 2015. 

The Company intends to initiate a search for a replacement CFO and until such time a new CFO is appointed, Zhiping Wang, President and Chief Executive Officer of the Company, will serve as interim CFO effective July 31, 2015.

About Asia Bio-Chem Group Corp.
Asia Bio-Chem Group, through its wholly-owned subsidiaries in the People's Republic of China, is in the business of processing corn into cornstarch, germ and gluten for sale into the domestic Chinese market.  From its plants in Liaoning and Heilongjiang Province, the Company has a total processing capacity of 1.5 million tonnes of corn per year.

This news release contains certain statements that may be deemed "forward looking statements". Forward looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects,", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although the Company believes the expectations expressed in such forward looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in forward looking statements. Forward looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. The Company undertakes no obligation to update these forward looking statements, except as required by law, in the event that management's beliefs, estimates or opinions, or other factors, should change.

SOURCE Asia Bio-Chem Group Corp.

For Investor Relations Information: Robert Wilson, Tel: [phone], Email: [email protected]